The secretory granules of human cells contain high levels of three serine proteinases: tryptase, chymase, and an enzyme similar to neutrophil cathepsin G. Understanding the structure and inhibitory mechanisms of proteinases from inflammatory cells, including the mast cell, is important for establishing the roles of proteinases and their inhibitors in inflammation. This proposal focuses on the continued characterization of mast cell proteinases and their mechanisms of inhibition. Using computer modeling techniques, the three-dimensional structure of chymase and its interactions with substrates, inhibitors, and proteoglycans will be investigated at the molecular level. Expression of analysis of mutant chymase. Mast cell cathepsin G and neutrophil cathepsin G differ in molecular weight, a dissimilarity that is likely related to differences in cellular processing. The biochemical and functional significance of the structural difference will be examined using mast cell cathepsin G isolated from skin. The plasma inhibitors alpha1-antichymotrypsin (ACT) and alpha1-proteinase inhibitor (alpha1-PI) inhibit human chymase. Kinetic and cleavage site analyses indicate that ACT and alpha1-PI may interact with chymase via distinct mechanisms. ACT and alpha1-PI variants will be synthesized by site directed mutagenesis and analyzed for their ability to function as substrates and/or inhibitors. These studies will provide insights into the mechanisms of serpin inhibition and thereby aid in the design of potent inflammatory proteinase inhibitors by genetic engineering. Tryptase has no apparent physiological inhibitor, but is regulated by an auto-activation process. This form of regulation is unique among serine proteinases. Investigations to establish the precise mechanism of tryptase auto-inactivation will involve defining conformational and structural changes as well as determining the factors that affect activity loss and reactivation. Definition of the properties of mast cell proteinases and the mechanisms of their inhibition by serpins will be useful for predicting behavior of proteinases and inhibitors in inflammatory processes and in the design of products which can interfere with these processes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
1R01AR042931-01
Application #
2082481
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Project Start
1993-12-27
Project End
1997-11-30
Budget Start
1993-12-27
Budget End
1994-11-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Dermatology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lazaar, Aili L; Plotnick, Michael I; Kucich, Umberto et al. (2002) Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol 169:1014-20
Plotnick, Michael I; Samakur, Madhurika; Wang, Zhi Mei et al. (2002) Heterogeneity in serpin-protease complexes as demonstrated by differences in the mechanism of complex breakdown. Biochemistry 41:334-42
Solivan, Suzanne; Selwood, Trevor; Wang, Zhe Mei et al. (2002) Evidence for diversity of substrate specificity among members of the chymase family of serine proteases. FEBS Lett 512:133-8
Cooley, J; Takayama, T K; Shapiro, S D et al. (2001) The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40:15762-70
Estebanez-Perpina, E; Fuentes-Prior, P; Belorgey, D et al. (2000) Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol Chem 381:1203-14
Groutas, W C; Schechter, N M; He, S et al. (1999) Human chymase inhibitors based on the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold. Bioorg Med Chem Lett 9:2199-204
Pereira, P J; Wang, Z M; Rubin, H et al. (1999) The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity. J Mol Biol 286:163-73
Selwood, T; McCaslin, D R; Schechter, N M (1998) Spontaneous inactivation of human tryptase involves conformational changes consistent with conversion of the active site to a zymogen-like structure. Biochemistry 37:13174-83
Wang, Z; Walter, M; Selwood, T et al. (1998) Recombinant expression of human mast cell proteases chymase and tryptase. Biol Chem 379:167-74
Schechter, N M; Brass, L F; Lavker, R M et al. (1998) Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol 176:365-73

Showing the most recent 10 out of 19 publications